- Datum24.02.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
Jens Klatt
Moderator
Mirum Pharmaceuticals Inc. Aktie
Verkaufen
Kaufen
Mirum Pharmaceuticals Inc. Chart
Mirum Pharmaceuticals Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-1,34 %
Intraday
4,82 %
1 Woche
10,35 %
1 Monat
26,84 %
Seit Jahresbeginn
88,60 %
1 Jahr
123,95 %
3 Jahre
184,28 %
5 Jahre
Wikifolio
Passender Service zu Mirum Pharmaceuticals Inc.
Webinar zu Mirum Pharmaceuticals Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)23,140-54,234
- Jahrestief / Hoch ($)40,550-54,234
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Mirum Pharmaceuticals Inc.
Keine Dividenden verfügbar
Termine von Mirum Pharmaceuticals Inc.
Keine aktuellen Termine
Beschreibung
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
